Influenza A/H1N1 in 2009: a pandemic in evolution

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

Iain Stephenson has received funding from manufacturers of influenza vaccines, including Novartis Vaccines and GSK for scientific research, and received consultancy or speakers fees and support for travel to scientific meetings from Novartis Vaccines, GSK and Baxter Vaccines. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.